Emergency Flu Response Act of 2004

Bill: 108-hr-5409
Sponsor: Rep. Lowey, Nita M. [D-NY-18]
Introduced: 2004-11-19 in the House
Policy area: Health
Subjects: Arts, Culture, Religion
Aspirin
Canada
Caregivers
Child health
Chronically ill
Civil Rights and Liberties, Minority Issues
Clinical trials
Commerce
Compensation (Law)
Congress
Congressional agencies
Congressional employees
Congressional reporting requirements
Discrimination in employment
Dismissal of employees
Drug approvals
Drug industry
East Asia
Economics and Public Finance
Emergency Management
Emergency medicine
Eminent domain
Employee rights
Europe
European Union
Families
Federal aid to health facilities
Federal employees
Federal libraries
Federal mandates
Foreign Trade and International Finance
Geriatrics
Government Accountability Office (GAO)
Government Operations and Politics
Government liability
Government paperwork
Government procurement
Governmental investigations
Health education
Imports
Infants
Influenza
Japan
Labor and Employment
Law
Library of Congress
Licenses
Long-term care
Marketing
Medical personnel
Nursing homes
Pregnant women
Preventive medicine
Prices
Public health administration
Public service advertising
Seniority in employment
Social Welfare
Standards
Switzerland
Vaccination
Vaccines
Wages
Wholesale trade
Women
Women's health

Summary:
action_date: 2004-11-19
text: 
Emergency Flu Response Act of 2004 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to immediately declare the shortage of the influenza vaccine to be a public health emergency justifying an authorization of the use of unapproved products.
 
Requires the Secretary to: (1) consult with certain foreign countries to assess the availability of excess vaccines; (2) determine whether such vaccines meet the criteria for emergency authorization; (3) purchase, import, and distribute such vaccines; (4) award a grant to each State to develop and implement a plan to respond to the current shortage; and (5) establish a program to purchase and redistribute excess doses for administration to individuals in priority areas.
 
Requires the head of each executive agency and the Attending Physician of the Capitol to ensure that vaccines are administered only to employees in priority groups and to provide the Secretary with any excess doses for redistribution.
 
Allows the Secretary to purchase any approved drug to treat influenza for inclusion in the Strategic National Stockpile.
 
Requires the Secretary, acting through the Director of the National Institutes of Health (NIH), to conduct clinical trials to determine whether a diluted influenza vaccine is effective in priority groups.
 
Establishes the National Quarantine Compensation Program to pay individuals subject to a State or Federal quarantine order an amount equal to lost wages. Prohibits an employer from discharging or discriminating against such individuals.
 
Allows the Secretary, upon determining that measures taken under this Act have not been effective, to: (1) take additional measures necessary to protect the public health; and (2) require manufacturers or anyone in possession of the vaccine to sell their supply to the Federal Government.


Legislative actions:
action_date: 2004-12-01
text: Referred to the Subcommittee on Health.
action_date: 2004-11-19
text: Referred to the House Committee on Energy and Commerce.
action_date: 2004-11-19
text: Introduced in House
action_date: 2004-11-19
text: Introduced in House